Fig. 4From: Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 cases30-2 HVF of npAIR patient (patient 5) managed with valacyclovir. a Field defects at presentation. b Partial recovery of the visual fields after a 4-week course of treatment with valacyclovir. c Resolution of visual field defects at most recent follow-up (3 years after presentation)Back to article page